🎙️ On this episode of #CareerOnPurpose, hear powerful stories from two incredible colleagues about their experiences with breast cancer and the creation of Breast Friends, a division of Merck's Women's Network employee business resource group. Check out the full episode to hear Hayley and Claire discuss their careers, why they started Breast Friends and how this group provides support for people all across the company: http://merck.us/47ShKFh
About us
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ
- Website
-
http://merck.us/2J2xAUh
External link for Merck
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Rahway, New Jersey
- Type
- Public Company
- Specialties
- Pharmaceutical
Locations
-
Primary
126 E Lincoln Ave
P.O. Box 2000
Rahway, New Jersey 07065, US
-
351 N Sumneytown Pike
North Wales, PA 19454, US
Employees at Merck
Updates
-
Today, we announced the completion of our acquisition of a novel investigational bispecific antibody from Curon Biopharmaceutical with applications spanning both B-cell malignancies and autoimmune diseases. We look forward to building upon the foundational work started by the Curon team. Read more: http://merck.us/3ZLG4pZ
-
Put yourself at the center of our leading-edge science by finding career opportunities in #research and development. See exciting and innovative open roles in our R&D team here: http://merck.us/4cBCSAX #MerckCareers
-
Before committing to a specific career path, Hannah was able to explore a range of opportunities through our Manufacturing Leadership Development Program (MLDP), a three-year rotational program designed to offer real career experience. Join our company and help us transform the future of manufacturing: http://merck.us/3RxXlOS #MerckCareers #ManufacturingJobs
-
Did you know our scientists published more than 1,400 papers last year in numerous peer-reviewed publications? We encourage all of our scientists and postdoc research fellows to be active members of the scientific community. Check out their publications here: http://merck.us/45iXw5Y
-
At our company, diversity, equity and inclusion is ingrained in our DNA. Read our latest blog to learn more about our commitment to fostering a workplace culture that values and embraces diversity in all its forms: http://merck.us/3XPiIhX #DiversityandInclusion #LifeAtMerck
-
For Dr. Priya Agrawal, MD (BMBCh), MPH, health equity isn’t just her job, it’s personal. Hear how her experiences growing up led to her to help launch Merck for Mothers, our initiative to bring high-quality maternity care to women across the world.
-
Looking for a career that looks beyond diplomas and degrees? Our #skillsfirst job opportunities value your unique experiences that can bring our leading-edge science to help people. Check out open roles to see where your skills can take you: http://merck.us/3VPdUbp #MerckCareers
-
Why did Matthew Cruz, PhD choose Merck for his postdoc? Host Andrew Latham delves into his motivation to make a meaningful difference in patients' lives. This is Pt. 2 of 'Scientist on the Street' in honor of #NationalPostDoc Appreciation Week. #NPAW2024 http://merck.us/3XvSSOH
Affiliated pages
Similar pages
Browse jobs
Stock
MRK
NYSE
20 minutes delay
$112.93
-1.81 (-1.578%)
- Open
- 114.61
- Low
- 112.73
- High
- 114.61
Data from Refinitiv
See more info on